SEC Form 4 · accession 0001645627-18-000064
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Oct 5, 2018
Accepted (ET)
Oct 9, 2018 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 5, 2018 | P | 2,000 | $0.054 | A | 25,995,898 | D | |
| Common Stock | Oct 5, 2018 | P | 1,000 | $0.0507 | A | 25,996,898 | D | |
| Common Stock | Oct 5, 2018 | P | 1,000 | $0.0507 | A | 25,997,898 | D | |
| Common Stock | Oct 5, 2018 | P | 1,000 | $0.0507 | A | 25,998,898 | D | |
| Common Stock | Oct 5, 2018 | P | 1,000 | $0.0516 | A | 25,999,898 | D | |
| Common Stock | Oct 5, 2018 | P | 1,000 | $0.0516 | A | 26,000,898 | D | |
| Common Stock | Oct 5, 2018 | P | 1,000 | $0.0516 | A | 26,001,898 | D | |
| Common Stock | Oct 5, 2018 | P | 2,000 | $0.0516 | A | 26,003,898 | D | |
| Common Stock | Oct 8, 2018 | P | 1,000 | $0.0506 | A | 26,004,898 | D | |
| Common Stock | Oct 8, 2018 | P | 1,000 | $0.0505 | A | 26,005,898 | D | |
| Common Stock | Oct 8, 2018 | P | 2,000 | $0.0505 | A | 26,007,898 | D | |
| Common Stock | Oct 8, 2018 | P | 700 | $0.051 | A | 26,008,598 | D | |
| Common Stock | Oct 8, 2018 | P | 300 | $0.0505 | A | 26,008,898 | D | |
| Common Stock | Oct 8, 2018 | P | 1,000 | $0.0505 | A | 26,009,898 | D | |
| Common Stock | Oct 8, 2018 | P | 1,000 | $0.0508 | A | 26,010,898 | D |
Table II — derivative securities
No Table II lines on this filing.